Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan
· Delayed Price · Currency is TWD 29.35
-0.65 (-2.17%)
Mar 9, 2026, 1:30 PM CST
TPEX:4111 Revenue
Chi Sheng Pharma & Biotech had revenue of 342.14M TWD in the quarter ending September 30, 2025, with 20.36% growth. This brings the company's revenue in the last twelve months to 1.36B, up 23.28% year-over-year. In the year 2024, Chi Sheng Pharma & Biotech had annual revenue of 1.17B with 9.86% growth.
Revenue (ttm)
1.36B
Revenue Growth
+23.28%
P/S Ratio
1.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.17B | 104.57M | 9.86% |
| Dec 31, 2023 | 1.06B | -82.21M | -7.19% |
| Dec 31, 2022 | 1.14B | 120.78M | 11.81% |
| Dec 31, 2021 | 1.02B | 42.94M | 4.38% |
| Dec 31, 2020 | 979.36M | -43.60M | -4.26% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.25B |
| Crystalvue Medical | 949.05M |
| Perfect Medical Industry | 737.27M |
| Lagis Enterprise | 470.29M |
| Unicon Optical | 747.16M |
| ICARES Medicus | 1.09B |
| Concord Medical | 905.31M |
| Maxigen Biotech | 792.49M |